Santiago Rivera - Publications

Affiliations: 
Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France 

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Migliorati M, Manrique C, Rahrah M, Escoffier G, El Ahmadi A, Girard SD, Khrestchatisky M, Rivera S, Baranger K, Roman FS. The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36093693 DOI: 10.3233/JAD-220281  0.312
2022 Pilat D, Paumier JM, García-González L, Louis L, Stephan D, Manrique C, Khrestchatisky M, Di Pasquale E, Baranger K, Rivera S. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65. PMID 35277173 DOI: 10.1186/s12974-022-02407-z  0.454
2021 Arnst N, Belio-Mairal P, García-González L, Arnaud L, Greetham L, Nivet E, Rivera S, Dityatev A. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes. Cells. 10. PMID 34359875 DOI: 10.3390/cells10071705  0.396
2021 García-González L, Paumier JM, Louis L, Pilat D, Bernard A, Stephan D, Jullien N, Checler F, Nivet E, Khrestchatisky M, Baranger K, Rivera S. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727. PMID 34117802 DOI: 10.1096/fj.202100593R  0.404
2020 Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry. PMID 32459966 DOI: 10.1021/Acs.Jmedchem.0C00352  0.497
2019 Rochais C, Lecoutey C, Hamidouche K, Giannoni P, Gaven F, Cem E, Mignani S, Baranger K, Freret T, Bockaert J, Rivera S, Boulouard M, Dallemagne P, Claeysen S. Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology. PMID 31881553 DOI: 10.1111/Bph.14964  0.391
2019 García-González L, Pilat D, Baranger K, Rivera S. Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244. PMID 31607898 DOI: 10.3389/Fnagi.2019.00244  0.532
2019 Baranger K, van Gijsel-Bonnello M, Stephan D, Carpentier W, Rivera S, Khrestchatisky M, Gharib B, De Reggi M, Benech P. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31267473 DOI: 10.1007/S13311-019-00754-Z  0.425
2019 Rivera S, García-González L, Khrestchatisky M, Baranger K. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls. PMID 31197405 DOI: 10.1007/S00018-019-03178-2  0.462
2019 Rivera S. Metalloproteinases in nervous system function and pathology: introduction. Cellular and Molecular Life Sciences : Cmls. PMID 31175371 DOI: 10.1007/S00018-019-03172-8  0.358
2018 Paumier JM, Py NA, García-González L, Bernard A, Stephan D, Louis L, Checler F, Khrestchatisky M, Baranger K, Rivera S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R. PMID 30332299 DOI: 10.1096/Fj.201801076R  0.531
2017 Baranger K, Giannoni P, Girard SD, Girot S, Gaven F, Stephan D, Migliorati M, Khrestchatisky M, Bockaert J, Marchetti-Gauthier E, Rivera S, Claeysen S, Roman FS. Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology. PMID 28844596 DOI: 10.1016/J.Neuropharm.2017.08.031  0.439
2017 van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, Gharib B. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. Plos One. 12: e0175369. PMID 28410378 DOI: 10.1371/Journal.Pone.0175369  0.382
2016 Baranger K, Bonnet AE, Girard SD, Paumier JM, García-González L, Elmanaa W, Bernard A, Charrat E, Stephan D, Bauer C, Moschke K, Lichtenthaler SF, Roman FS, Checler F, Khrestchatisky M, ... Rivera S, et al. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience. 9: 163. PMID 28119565 DOI: 10.3389/Fnmol.2016.00163  0.557
2016 Baranger K, Khrestchatisky M, Rivera S. MT5-MMP, just a new APP processing proteinase in Alzheimer's disease? Journal of Neuroinflammation. 13: 167. PMID 27349644 DOI: 10.1186/S12974-016-0633-4  0.545
2016 Giannoni P, Arango-Lievano M, Neves ID, Rousset MC, Barranger K, Rivera S, Jeanneteau F, Claeysen S, Marchi N. Cerebrovascular pathology during the progression of experimental Alzheimer's disease. Neurobiology of Disease. PMID 26774030 DOI: 10.1016/J.Nbd.2016.01.001  0.405
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, ... ... Rivera S, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. PMID 26202697 DOI: 10.1007/S00018-015-1992-1  0.73
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, ... ... Rivera S, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Cellular and Molecular Life Sciences. DOI: 10.1007/s00018-015-1992-1  0.711
2014 Baranger K, Rivera S, Liechti FD, Grandgirard D, Bigas J, Seco J, Tarrago T, Leib SL, Khrestchatisky M. Endogenous and synthetic MMP inhibitors in CNS physiopathology. Progress in Brain Research. 214: 313-51. PMID 25410364 DOI: 10.1016/B978-0-444-63486-3.00014-1  0.461
2014 Py NA, Bonnet AE, Bernard A, Marchalant Y, Charrat E, Checler F, Khrestchatisky M, Baranger K, Rivera S. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Frontiers in Aging Neuroscience. 6: 247. PMID 25278878 DOI: 10.3389/Fnagi.2014.00247  0.714
2014 Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, Benech P, Féron F. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Molecular Neurodegeneration. 9: 33. PMID 25213090 DOI: 10.1186/1750-1326-9-33  0.343
2014 Thevenard J, Verzeaux L, Devy J, Etique N, Jeanne A, Schneider C, Hachet C, Ferracci G, David M, Martiny L, Charpentier E, Khrestchatisky M, Rivera S, Dedieu S, Emonard H. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. Plos One. 9: e103839. PMID 25075518 DOI: 10.1371/Journal.Pone.0103839  0.415
2014 Girard SD, Jacquet M, Baranger K, Migliorati M, Escoffier G, Bernard A, Khrestchatisky M, Féron F, Rivera S, Roman FS, Marchetti E. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus. 24: 762-72. PMID 24596271 DOI: 10.1002/Hipo.22267  0.398
2013 Giannoni P, Gaven F, de Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS, Valjent E, Marin P, Bockaert J, Rivera S, Claeysen S. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 5: 96. PMID 24399967 DOI: 10.3389/Fnagi.2013.00096  0.368
2013 Crouzin N, Baranger K, Cavalier M, Marchalant Y, Cohen-Solal C, Roman FS, Khrestchatisky M, Rivera S, Féron F, Vignes M. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. Plos One. 8: e74667. PMID 24069328 DOI: 10.1371/Journal.Pone.0074667  0.668
2013 Ould-Yahoui A, Sbai O, Baranger K, Bernard A, Gueye Y, Charrat E, Clément B, Gigmes D, Dive V, Girard SD, Féron F, Khrestchatisky M, Rivera S. Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells. Cell Transplantation. 22: 993-1010. PMID 23043957 DOI: 10.3727/096368912X657468  0.446
2013 Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, Marchetti E, Khrestchatisky M, Rivera S, Roman FS. Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 781-96. PMID 23042214 DOI: 10.3233/Jad-2012-120982  0.431
2012 Marchalant Y, Baranger K, Wenk GL, Khrestchatisky M, Rivera S. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 9: 10. PMID 22248015 DOI: 10.1186/1742-2094-9-10  0.679
2011 Wójcik-Stanaszek L, Sypecka J, Szymczak P, Ziemka-Nalecz M, Khrestchatisky M, Rivera S, Zalewska T. The potential role of metalloproteinases in neurogenesis in the gerbil hippocampus following global forebrain ischemia. Plos One. 6: e22465. PMID 21799862 DOI: 10.1371/Journal.Pone.0022465  0.401
2011 Gueye Y, Ferhat L, Sbai O, Bianco J, Ould-Yahoui A, Bernard A, Charrat E, Chauvin JP, Risso JJ, Féron F, Rivera S, Khrestchatisky M. Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration? Glia. 59: 750-70. PMID 21360755 DOI: 10.1002/Glia.21146  0.42
2011 Rivera S. F5-04-05: The MMP/TIMP system in Alzheimer's disease Alzheimer's & Dementia. 7: S813-S813. DOI: 10.1016/j.jalz.2011.05.2347  0.349
2010 Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, Mehanna A, Risso JJ, Chauvin JP, Fenouillet E, Rivera S, Khrestchatisky M. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia. 58: 344-66. PMID 19780201 DOI: 10.1002/glia.20927  0.354
2009 Ould-yahoui A, Tremblay E, Sbai O, Ferhat L, Bernard A, Charrat E, Gueye Y, Lim NH, Brew K, Risso JJ, Dive V, Khrestchatisky M, Rivera S. A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. Plos One. 4: e8289. PMID 20011518 DOI: 10.1371/Journal.Pone.0008289  0.348
2008 Sbai O, Ferhat L, Bernard A, Gueye Y, Ould-Yahoui A, Thiolloy S, Charrat E, Charton G, Tremblay E, Risso JJ, Chauvin JP, Arsanto JP, Rivera S, Khrestchatisky M. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Molecular and Cellular Neurosciences. 39: 549-68. PMID 18817873 DOI: 10.1016/J.Mcn.2008.08.004  0.445
2006 Chaillan FA, Rivera S, Marchetti E, Jourquin J, Werb Z, Soloway PD, Khrestchatisky M, Roman FS. Involvement of tissue inhibition of metalloproteinases-1 in learning and memory in mice. Behavioural Brain Research. 173: 191-8. PMID 16860884 DOI: 10.1016/J.Bbr.2006.06.020  0.337
2006 Ogier C, Bernard A, Chollet AM, LE Diguardher T, Hanessian S, Charton G, Khrestchatisky M, Rivera S. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia. 54: 272-84. PMID 16845676 DOI: 10.1002/Glia.20349  0.35
2005 Jourquin J, Tremblay E, Bernard A, Charton G, Chaillan FA, Marchetti E, Roman FS, Soloway PD, Dive V, Yiotakis A, Khrestchatisky M, Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. The European Journal of Neuroscience. 22: 2569-78. PMID 16307599 DOI: 10.1111/j.1460-9568.2005.04426.x  0.308
2004 Rivera S, Jourquin J, Ogier C, Bernard A, Charton G, Tremblay E, Khrestchatisky M. [The MMP/TIMP system in the nervous system]. Mã©Decine Sciences : M/S. 20: 55-60. PMID 14770364 DOI: 10.1051/medsci/200420155  0.358
2003 Jourquin J, Tremblay E, Décanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M, Rivera S. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. The European Journal of Neuroscience. 18: 1507-17. PMID 14511330 DOI: 10.1046/J.1460-9568.2003.02876.X  0.34
2003 Khrestchatisky M, Jourquin J, Ogier C, Charton G, Bernard A, Tremblay E, Rivera S. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system]. Journal De La Sociã©Tã© De Biologie. 197: 133-44. PMID 12910628  0.374
2002 Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. The European Journal of Neuroscience. 15: 19-32. PMID 11860503 DOI: 10.1046/j.0953-816x.2001.01838.x  0.31
Show low-probability matches.